-- 摩根士丹利週三發布的研究報告指出，Brinker International (EAT) 仍然是全方位服務餐飲領域極具吸引力的選擇，股價回檔是投資者入場的良機。 該公司公佈的第三財季業績符合預期，摩根士丹利表示，在門市翻新和門市擴張的推動下，未來兩位數獲利成長的可能性很高。 分析師指出，儘管第三財季同店銷售額低於預期，天氣和假日因素對營收成長造成了2.1%的負面影響，但隨著季度推進，趨勢有所改善，預計4月份客流量增加，同店銷售額預計將實現中等個位數成長。 摩根士丹利目前預計該公司第四財季調整後每股收益為3.10美元，高於先前預期的3.05美元。對於2026財年全年，摩根士丹利目前預計該公司調整後每股收益為12.52美元，高於先前預期的12.37美元。 受大宗商品通膨和餐飲成本上漲的影響，該公司第三季餐廳利潤率較上年同期下降。但報告指出，2027年的菜單創新可望成為推動消費者升級消費的契機。 該券商重申了對該股的「增持」評級，並將目標股價從每股205美元上調至207美元。
Price: $150.88, Change: $+3.07, Percent Change: +2.08%
Alignment Healthcare (ALHC) reported Q1 earnings late Thursday of $0.05 per diluted share, compared with the loss of $0.05 a year earlier.Analysts polled by FactSet expected earnings of $0.01.Revenue in the three months ended March 31 rose to $1.24 billion from $926.9 million a year ago.Analysts surveyed by FactSet expected $1.22 billion.The company expects revenue of $1.3 billion to $1.32 billion in Q2 and $5.16 billion to $5.21 billion in the full year.Analysts project $1.31 billion in Q2 and $5.17 billion in 2026.Alignment Healthcare shares fell 10% in after-hours trading.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:COLM posted Q1 2026 EPS of $0.65 vs. $0.75 prior year, $0.30 above consensus on flat net sales of $779M, $21M above estimates. International diversification proved valuable with EMEA surging 35% and LAAP growing 5%, offsetting a 10% U.S. decline, while gross margin contracted 20 bps to 50.7% primarily from a 310-bp incremental tariff impact. We believe the international growth strategy is effectively insulating the company from U.S. tariff headwinds and positioning it for sustained global expansion. Management raised full-year EPS guidance to $3.55-$4.00 from prior $3.20-$3.65 and operating margin guidance to 6.7%-7.5% reflecting better tariff conditions. The company maintains its fortress balance sheet with $535.4M cash and no debt while executing a $150M share repurchase program. We are impressed with international performance driving growth and expect continued momentum from the ACCELERATE Growth Strategy targeting younger consumers, with shares trading at 17x forward EPS guidance.